Mach7 Technologies (ASX:M7T) Forward Dividend Yield %: 0.00% (As of Jun. 27, 2026)


ASX:M7T Mach7 Technologies Ltd ASX:M7T
35 GF Score
Price A$0.30
GF Value A$0.83
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mach7 Technologies Forward Dividend Yield %?

Mach7 Technologies ASX:M7T -1.67% 35 Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.83 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Mach7 Technologies ranks worse than 363636% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of Mach7 Technologies is 0.00%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of Mach7 Technologies is 0.00%.

ASX:M7T's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.48
* Ranked among companies with meaningful Forward Dividend Yield % only.

Mach7 Technologies's Dividends per Share for the six months ended in Dec. 2025 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Mach7 Technologies  (ASX:M7T) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Mach7 Technologies Forward Dividend Yield % Related Terms


ASX:M7T vs VEEV, BTSG, TEM: Forward Dividend Yield % Comparison

For the Health Information Services subindustry, Mach7 Technologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies Forward Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's Forward Dividend Yield % falls into.


ASX:M7T
35GF Score
Mach7 Technologies Ltd ASX:M7T
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mach7 Technologies Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Mach7 Technologies (ASX:M7T) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mach7 Technologies and its competitors. According to the industry distribution chart, Mach7 Technologies ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Mach7 Technologies' Forward Dividend Yield % too high?
Mach7 Technologies' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Mach7 Technologies ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' Forward Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #999999 out of 275 companies for Forward Dividend Yield %. This places Mach7 Technologies in the lower half of its industry. The industry median Forward Dividend Yield % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.48, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.83, compared to a current price of A$0.30 — trading 64.5% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?

Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued. The current stock price of A$0.30 is trading 64.5% below its estimated GF Value™ of A$0.83. GuruFocus considers Mach7 Technologies to be Possible Value Trap.

Key valuation signals for ASX:M7T:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: A$0.83 vs. price of A$0.30 (64.5% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mach7 Technologies Business Description

Other Exchanges TDMMF:USA
Address 120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score

Get the complete analysis for ASX:M7T

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.30
Price
A$0.83
GF Value